AI Assistant
Blog
Pricing
Log In
Sign Up
Combination treatment with hENT1 and miR-143 reverses gemcitabine resistance in triple-negative breast cancer
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
